↓ Skip to main content

Focused Ultrasound: An Emerging Therapeutic Modality for Neurologic Disease

Overview of attention for article published in Neurotherapeutics, April 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
153 Mendeley
Title
Focused Ultrasound: An Emerging Therapeutic Modality for Neurologic Disease
Published in
Neurotherapeutics, April 2017
DOI 10.1007/s13311-017-0515-1
Pubmed ID
Authors

Paul S Fishman, Victor Frenkel

Abstract

Therapeutic ultrasound is only beginning to be applied to neurologic conditions, but the potential of this modality for a wide spectrum of brain applications is high. Engineering advances now allow sound waves to be targeted through the skull to a brain region selected with real time magnetic resonance imaging and thermography, using a commercial array of focused emitters. High intensities of sonic energy can create a coagulation lesion similar to that of older radiofrequency stereotactic methods, but without opening the skull. This has led to the recent Food and Drug Administration approval of focused ultrasound (FUS) thalamotomy for unilateral treatment of essential tremor. Clinical studies of stereotactic FUS for aspects of Parkinson's disease, chronic pain, and refractory psychiatric indications are underway, with promising results. Moderate-intensity FUS has the potential to safely open the blood-brain barrier for localized delivery of therapeutics, while low levels of sonic energy can be used as a form of neuromodulation.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 153 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 153 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 22 14%
Student > Bachelor 21 14%
Student > Ph. D. Student 20 13%
Student > Master 13 8%
Other 8 5%
Other 27 18%
Unknown 42 27%
Readers by discipline Count As %
Medicine and Dentistry 25 16%
Engineering 24 16%
Neuroscience 23 15%
Agricultural and Biological Sciences 9 6%
Nursing and Health Professions 4 3%
Other 20 13%
Unknown 48 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 November 2021.
All research outputs
#15,173,117
of 25,382,440 outputs
Outputs from Neurotherapeutics
#971
of 1,308 outputs
Outputs of similar age
#170,500
of 323,961 outputs
Outputs of similar age from Neurotherapeutics
#10
of 16 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,308 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.2. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 323,961 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.